Skip to main content

Table 2 Ceiling Effect of EQ-5D-Y-3L and EQ-5D-Y-5L

From: Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients

Time

Instrument

Ceiling effect (%)

Patients reporting no problems (%)

Mobility

Looking after myself

Usual activities

Pain/ discomfort

Worried/sad/unhappy

Overall (11111)

tbaseline

EQ-5D-Y-3L

69.9

62.6

51.0

39.2

65.0

21.3

EQ-5D-Y-5L

71.7

60.1

48.6

36.0

65.7

17.5

p value*

0.54

0.27

0.36

0.19

0.88

0.88

tfollowup

EQ-5D-Y-3L

73.8

74.1

66.1

62.9

68.2

53.5

EQ-5D-Y-5L

74.5

74.8

66.8

60.1

68.9

50.7

p value*

0.63

1.00

1.00

0.09

1.00

1.00

Disease Group

Instrument

Ceiling effect per disease group at baseline (%)

Patients reporting no problems (%)

Mobility

Looking after myself

Usual activities

Pain/ discomfort

Worried/sad/unhappy

Overall (11111)

Thalassemia

EQ-5D-Y-3L

92.6

75

95.6

70.6

80.9

57.4

 

EQ-5D-Y-5L

89.7

79.4

97.1

63.2

75

58

Acutely Ill

EQ-5D-Y-3L

69.1

34.7

34.7

28.2

58.1

13.1

 

EQ-5D-Y-5L

71.8

25

29.8

25.8

60.5

18

AcLL

EQ-5D-Y-3L

65

60

50

42.5

47.5

16.4

 

EQ-5D-Y-5L

70

57.5

45

40

47.5

16

Haemophilia

EQ-5D-Y-3L

48.1

87

59.3

22.2

74.1

13.1

 

EQ-5D-Y-5L

50

85.2

66.7

22.2

79.6

8

  1. *The p value was tested using McNemar test with level of confidence interval < 0.05